glp 1 agonists and sglt2 inhibitors combination Combining glucagon-like peptide-1 receptor (GLP-1RAs) sodium-glucose cotransporter-2 (SGLT2is) in patients with type 2 diabetes mellitus (T2DM) | Cardiovascular Diabetology Influence of combination therapy with

Additionally, because Mounjaro delays gastric emptying, there is a rare risk of pulmonary aspiration during general anaesthesia or deep sedation

10.1038/s41467-022-32307-y

So, what does this suggest for the future of obesity treatment

Human data followed: a prospective, double-blind RCT in Diabetes Care found that daily administration of Lactobacillus reuteri SD5865 increased glucose-stimulated GLP-1 release by 76% compared to placebo, with corresponding increases in insulin secretion

Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, Ohman P, Frederich R, Wiviott SD, Hoffman EB, Cavender MA, Udell JA, Desai NR, Mosenzon O, McGuire DK, Ray KK, Leiter LA, Raz I: SAVOR-TIMI 53 Steering Committee and Investigators

2010;123(5):468.e9468.e17